Pre-Made Efaprinermin Alfa Biosimilar, Fusion Protein targeting TNFRSF18 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting AITR/CD357/ENERGEN/GITR/GITR-D for drug discovery and mechanism of action (MOA) research

Cat:GMP-Bios-INN-810

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

SKU GMP-Bios-INN-810 Category Tag

Product Details

Pre-Made Efaprinermin Alfa Biosimilar, Fusion Protein targeting TNFRSF18 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting AITR/CD357/ENERGEN/GITR/GITR-D is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Efaprinermin Alfa contains tumor necrosis factor superfamily protein TNFSF18 (human) trimer fusion protein with immunoglobulin g1 (human fc fragment). It is used for the high-value therapeutic targets for inflammatory or immune modulation in autoimmune diseases, transplant recipients, or cancers.

Products Name (INN Index)

Pre-Made Efaprinermin Alfa Biosimilar, Fusion Protein targeting TNFRSF18 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting AITR/CD357/ENERGEN/GITR/GITR-D

INN Name

efaprinermin alfa

Target

TNFRSF18

Format

Fusion Protein

Derivation

Human

Species Reactivity

Human

CH1 Isotype

Fusion – [TNFSF18 (TNF superfamily member 18, AITRL, TL6, GITRL)]2 – IGHG1 Fc (Fragment constant)

VD LC

Fusion – [TNFSF18 (TNF superfamily member 18, AITRL, TL6, GITRL)]2 – IGHG1 Fc (Fragment constant)

Highest_Clin_Trial (Jan '20)

NA

Est. Status

NA

100% SI Structure

NA

99% SI Structure

NA

95-98% SI Structure

NA

Year Proposed

NA

Companies

OncoMed Pharmaceuticals (Redwood City CA USA)

Conditions Approved

NA

Conditions Active

NA

Conditions Discontinued

NA

Development Tech

NA

Previous Name

NA

Gm Offical Target Name

TNFRSF18

Package

, ,

Genemeidi Omicron Variant Products
test
Previous slide
Next slide